Effect of Agonist Contract Relax Versus Antagonist Contract Relax in Chronic Stroke Patient.
1 other identifier
interventional
112
1 country
2
Brief Summary
It will be a randomized control trial with 112 patients which will be divided into two groups of 56 patients in each group. Participants will recruit through convenient sampling techniques. Outcome measures are range of motion and spasticity. The protocol was implemented three days per week for eight consecutive weeks. Data will be collected at baseline and 8 th week after intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Nov 2022
Shorter than P25 for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 7, 2022
CompletedFirst Submitted
Initial submission to the registry
July 15, 2023
CompletedFirst Posted
Study publicly available on registry
July 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2023
CompletedAugust 3, 2023
August 1, 2023
9 months
July 15, 2023
August 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Modified Ashworth Scale.
The assessment involves extending the limb of the parent from a state of utmost flexion to utmost extension, identifying the point at which initial mild resistance was encountered. Following that, the modified Ashworth Scale is employed while transitioning the limb from extension to flexion. Interrater reliability studies utilizing the MAS have yielded varied results, ranging from moderate to good.
it will measure change in spasticity at baseline and at 8th week
universal goniometer
The universal goniometer (UG) is a widely employed tool for assessing range of motion.Range of motion refers to the complete extent of movement possible at a specific joint. In a normal ankle, the range of motion typically spans from around 20ºof dorsiflexion to 50º of plantar flexion. For normal walking, a combined motion of approximately 24º to 30º (including both dorsiflexion and plantar flexion) is required.
it will measure change in range of motion at baseline and at 8th week
Study Arms (2)
Agonist Contract-relax group:
EXPERIMENTALIn the agonist contract-relax group, participants were positioned in a supine position. A trained physiotherapist then passively dorsiflexed the ankle to its maximum available range and held it for 15 seconds, while ensuring that the knee remained straight by placing a hand on it. Following this, participants were instructed to perform a maximal voluntary isometric 35 contraction of the planter flexors for five seconds, while maintaining the stretched position. After a 30-second rest period, the physiotherapist returned the ankle to the starting position of 0 degrees and repeat the procedure without any rest. This stretching protocol was repeated four times, with each repetition lasting 2 minutes. For the soleus muscles, the same procedure was performed, but with a slightly flexed initial position of the knee.
Antagonist contract-relax group:
EXPERIMENTALIn the antagonist stretching groups, participants were positioned in a supine position. A trained physiotherapist stretched the antagonist\'s muscle, and then participants were instructed to perform a maximal voluntary isometric contraction of dorsiflexion for 5 seconds while maintaining a stretched position. The knee was kept straight during this contraction. Following the contraction, the physiotherapist held the ankle at that angle for another 10 seconds by placing a hand on it. After a 30-second rest period, the physiotherapist returned the ankle to the starting position of 0 degrees and repeat the procedure without any rest intervals.
Interventions
Both groups received routine physical therapy, which encompasses various components such as electrotherapy, strength training for both lower and upper limbs, gait training, and occupational therapy.
antagonist contraction i used to improve spasticity and range of motion in stroke patients
agonist contraction is used to improve spasticity and range of motion in stroke patients
Eligibility Criteria
You may qualify if:
- Patients with a confirmed diagnosis of stroke by a neurologist.
- Both male and female patients are eligible.
- Age range between 40 to 60 years.
- Modified Ashworth Scale ranging from 0 to 2.
- Minimum muscle strength grade of 3
You may not qualify if:
- History of surgery on lower limb
- Who received injection therapies for reducing spasticity
- Lower extremity contracture
- Modified Ashworth scale of 3-4
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
sir Ganga Raam hospital lahore
Lahore, Pakistan
univerity of Lahore teaching hopital
Lahore, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2023
First Posted
July 24, 2023
Study Start
November 7, 2022
Primary Completion
July 30, 2023
Study Completion
July 30, 2023
Last Updated
August 3, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share